Coombs Test (Direct & Indirect) Explained: Positive Result Meaning, Report Reading & Importance (India 2026) | कूम्ब्स टेस्ट गाइड
Coombs Test Explained: Direct (DAT) & Indirect (IAT) — Normal Range, Positive Result & Haemolytic Anaemia (India 2026)
कूम्ब्स टेस्ट गाइड: DCT और ICT — पॉजिटिव रिजल्ट का मतलब, हेमोलिटिक एनीमिया और गर्भावस्था में उपयोग
Your doctor has ordered a "Coombs test" — and you may be wondering what it is and why. The Coombs test (also called the antiglobulin test) is ordered when a doctor suspects that the immune system is attacking and destroying red blood cells — a condition called autoimmune haemolytic anaemia. It is also an essential part of prenatal care in India for Rh-negative pregnant women (as the Indirect Coombs Test / ICT), and is routinely done before blood transfusions as a cross-matching step (compatibility testing). Understanding the two types — Direct Coombs Test (DCT) and Indirect Coombs Test (ICT) — is key to reading the report correctly.
This guide explains both Coombs tests in simple English and Hindi — what each measures, what positive vs negative means, the clinical conditions they detect, and what the next steps are. The Coombs test is always ordered alongside a CBC, peripheral blood smear, and LFT (for bilirubin) in the haemolytic anaemia workup. For reading lab reports generally, see our beginner's guide to blood test reports.
कूम्ब्स टेस्ट (एंटीग्लोबुलिन टेस्ट) तब मंगाया जाता है जब डॉक्टर को संदेह होता है कि प्रतिरक्षा प्रणाली लाल रक्त कोशिकाओं को नष्ट कर रही है (ऑटोइम्यून हेमोलिटिक एनीमिया)। यह Rh नेगेटिव गर्भवती महिलाओं में प्रसव पूर्व देखभाल और रक्त आधान संगतता के लिए भी आवश्यक है। Table of Contents / विषय सूची
What Is the Coombs Test? / कूम्ब्स टेस्ट क्या है?
The Coombs test — named after Robin Coombs, the British immunologist who developed it in 1945 — is an immunological blood test that detects antibodies or complement proteins attached to red blood cells, or free antibodies in blood serum that can attack red blood cells. The test uses a special reagent called antihuman globulin (AHG) — also called the Coombs reagent — which is an antibody produced in animals (originally rabbits) that binds to human immunoglobulins (IgG) and complement proteins (C3d) coating red cells. When AHG is mixed with antibody-coated red cells, it creates cross-links between them — producing visible clumping (agglutination) that indicates a positive result.
कूम्ब्स टेस्ट — 1945 में Robin Coombs द्वारा विकसित — एक इम्यूनोलॉजिकल रक्त परीक्षण है जो लाल रक्त कोशिकाओं से जुड़े एंटीबॉडी का पता लगाता है। AHG (एंटीह्यूमन ग्लोबुलिन) रीएजेंट जब एंटीबॉडी-लेपित RBC से मिलता है तो दृश्य क्लंपिंग (agglutination) बनाता है — पॉजिटिव परिणाम।Direct (DCT) vs Indirect (ICT) — Key Differences
| Feature / विशेषता | Direct Coombs Test (DCT / DAT) | Indirect Coombs Test (ICT / IAT) |
|---|---|---|
| What is tested | Patient's own red blood cells | Patient's blood serum (free antibodies) |
| What it detects | Antibodies/complement already COATING the patient's RBCs (in vivo sensitisation) | Free antibodies in serum that CAN react with test RBCs (in vitro) |
| Clinical question answered | "Are my RBCs being attacked right now?" | "Does my serum contain antibodies that could attack specific RBCs?" |
| Primary uses in India | Autoimmune haemolytic anaemia (AIHA); haemolytic transfusion reaction investigation; drug-induced haemolysis; HDN diagnosis in newborn | Antenatal antibody screening (Rh-negative pregnant women); pre-transfusion cross-matching; investigating unexpected antibodies |
| Positive result means | RBCs are coated with antibodies — ongoing haemolysis likely | Free antibodies present in serum — risk to recipient's RBCs or fetal RBCs |
| Negative result means | No antibodies coating RBCs — autoimmune haemolysis less likely | No clinically significant free antibodies detected in serum |
| Sample required | EDTA blood (whole blood — to preserve RBCs) | Clotted blood / serum |
| Also called | DAT (Direct Antiglobulin Test), DCT | IAT (Indirect Antiglobulin Test), ICT, antibody screen |
Reading Your Report — Positive vs Negative
The Coombs test result is reported as Positive or Negative, with positive results sometimes graded by strength (titre). Understanding the report:
कूम्ब्स टेस्ट परिणाम पॉजिटिव या नेगेटिव रिपोर्ट किया जाता है, पॉजिटिव परिणाम कभी-कभी शक्ति (टाइटर) द्वारा वर्गीकृत होते हैं।| Result / परिणाम | DCT (Direct) — meaning | ICT (Indirect) — meaning | Action needed |
|---|---|---|---|
| NEGATIVE | No antibodies coating patient's RBCs. Autoimmune haemolysis less likely — consider other causes of anaemia. | No clinically significant free antibodies in serum. Safe for transfusion with compatible blood. Rh-negative pregnant woman: not yet sensitised. | Investigate alternative causes of anaemia (iron, B12, thalassaemia). Repeat ICT at next antenatal visit as scheduled. |
| POSITIVE (1+) | Weak antibody coating — low-grade sensitisation. Mild ongoing haemolysis possible. May be clinically insignificant. | Weak antibodies present. May be clinically insignificant — requires antibody identification. Monitor in pregnancy. | Antibody identification (specificity testing) required. Clinical correlation with symptoms, haemoglobin, bilirubin, LDH. |
| POSITIVE (2+–4+) | Moderate to strong — significant antibody coating. Active haemolysis likely — anaemia, jaundice, raised LDH expected. | Significant free antibodies — higher titre indicates more sensitisation. In pregnancy: escalating fetal risk depending on titre and antibody specificity. | Haematologist/maternal-fetal medicine specialist consultation. Steroid therapy (for AIHA). Serial fetal monitoring in pregnancy (MCA Doppler). |
Causes of a Positive DCT
AIHA is divided into Warm AIHA (IgG antibodies active at 37°C — most common in India, 70% of cases; associated with lymphoma, SLE, chronic lymphocytic leukaemia, and idiopathic) and Cold AIHA (IgM antibodies active at cold temperatures — cold agglutinin disease; associated with Mycoplasma pneumoniae infection, EBV, lymphoma). Warm AIHA shows IgG-positive DCT; Cold AIHA shows C3d-positive DCT. Treatment: corticosteroids (prednisolone) first-line for Warm AIHA; avoid cold exposure for Cold AIHA; rituximab for refractory cases; splenectomy for chronic Warm AIHA unresponsive to steroids.
Many common medications cause a positive DCT by one of three mechanisms: drug adsorption (antibiotic attaches to RBC surface — penicillin, cephalosporins — most commonly seen in India), immune complex mechanism (drug-antibody complex deposits on RBC), and true autoantibody induction (drug triggers genuine anti-RBC autoantibodies — methyldopa classically; also fludarabine, cladribine). Common Indian drugs causing positive DCT: penicillin and amoxicillin (high-dose), cephalosporins (ceftriaxone, cefotaxime — increasingly common in Indian hospitals), methyldopa (still used for hypertension in pregnancy in India), NSAIDs, diclofenac, isoniazid (TB treatment — very relevant in India), dapsone, quinine/chloroquine (malaria treatment). A careful medication history is essential in any patient with positive DCT — stopping the offending drug often resolves haemolysis.
Both acute (within 24 hours) and delayed haemolytic transfusion reactions (3–14 days post-transfusion) cause a positive DCT — donor RBCs are coated by recipient's antibodies. Acute reactions are life-threatening (ABO incompatibility — wrong blood group given); delayed reactions from minor blood group antibodies (Kidd, Duffy, Kell) are less severe but cause unexplained anaemia days after transfusion with a new positive DCT. Investigation of any unexplained post-transfusion fever, haemoglobin drop, or jaundice must include DCT and antibody screen.
In a newborn with jaundice in the first 24 hours of life (always pathological — physiological jaundice does not appear before 24 hours), a positive DCT on cord blood or neonatal blood confirms maternal antibodies coating the baby's RBCs. The most common cause in India: ABO incompatibility (mother group O, baby group A or B — IgG anti-A or anti-B antibodies cross placenta) — usually mild. Rh incompatibility (Rh-negative mother, Rh-positive baby sensitised in previous pregnancy) — potentially severe. Neonatal DCT helps determine whether phototherapy and/or exchange transfusion is needed.
Positive DCT from AIHA secondary to systemic diseases: Systemic Lupus Erythematosus (SLE — see ANA guide) — AIHA occurs in 10–15% of SLE patients; positive DCT with active lupus flare alongside falling C3/C4. Lymphoma and CLL (B-cell lymphoproliferative disorders — most common secondary cause in adults). Mycoplasma pneumoniae pneumonia — cold agglutinin-mediated AIHA, especially in children in India. Viral infections (EBV infectious mononucleosis, CMV, HIV). Chronic liver disease.
Non-pathological positive DCT: cold agglutinins at room temperature testing (technical artefact — must test at 37°C to exclude); hyperglobulinaemia (polyclonal immunoglobulin elevation in infections, liver disease, myeloma — non-specific coating); recently transfused patients (transfused RBCs from donor with pre-existing antibodies); very high-dose intravenous immunoglobulin (IVIG) therapy. If DCT is positive but there is no haemolysis, no anaemia, and no jaundice — clinical significance is low, and the test can be repeated after eliminating technical causes.
ICT in Pregnancy — Rh Sensitisation Monitoring
The Indirect Coombs Test (ICT) is the single most important use of the Coombs test in routine Indian obstetric practice. Every Rh-negative pregnant woman must have serial ICT testing throughout pregnancy to detect and monitor Rh sensitisation — the production of anti-Rh D antibodies following exposure to Rh-positive fetal blood.
ICT भारतीय प्रसूति अभ्यास में कूम्ब्स टेस्ट का सबसे महत्वपूर्ण उपयोग है। हर Rh-नेगेटिव गर्भवती महिला को गर्भावस्था के दौरान Rh संवेदनशीलता का पता लगाने और निगरानी करने के लिए क्रमिक ICT परीक्षण करवाना चाहिए।A negative ICT in an Rh-negative pregnant woman means she has not yet produced anti-Rh D antibodies — she is unsensitised. This is the expected result in most Rh-negative pregnant women, especially in first pregnancies or when Anti-D has been properly given in previous pregnancies. Management: continue Anti-D prophylaxis schedule (28 weeks antenatal dose + postnatal dose within 72 hours of delivery if baby is Rh+). Repeat ICT at 28 weeks and again if any sensitising event occurs. A negative ICT at full term confirms safe delivery — no special neonatal measures for haemolysis based on Rh incompatibility.
A positive ICT means anti-Rh D (or other blood group) antibodies are present in the mother's serum. This indicates the mother's immune system has been sensitised — she has encountered Rh-positive blood at some point (previous pregnancy delivery, miscarriage, or transfusion). Once positive, Anti-D injection will no longer prevent further antibody production — the sensitisation is permanent. Management now focuses on monitoring the fetus: antibody titration (how high is the titre?), Middle Cerebral Artery Doppler (MCA PSV) ultrasound to detect fetal anaemia, and if severe — intrauterine transfusion. Maternal-fetal medicine specialist referral is essential.
A positive ICT result is expressed as a titre — a serial dilution measurement of how many antibodies are present: 1:1, 1:2, 1:4, 1:8, 1:16, 1:32, 1:64, 1:128, 1:256, etc. The critical titre (threshold of concern for fetal risk) in Indian obstetric practice is 1:16 or above for anti-Rh D antibodies — at this level and above, fetal anaemia becomes a real risk requiring Doppler assessment. Below 1:16: monthly titre monitoring, standard antenatal care. At 1:16 and above: MCA Doppler every 1–2 weeks; maternal-fetal medicine referral. Rising titre (e.g., 1:8 → 1:16 → 1:32 → 1:64) indicates progressive sensitisation and escalating fetal risk even if symptoms are absent.
While anti-Rh D is the most important, ICT can also detect other clinically significant alloantibodies that cause HDFN: anti-Kell (K antigen — more severe than Rh D; suppresses fetal erythropoiesis directly), anti-c (small-c Rh antigen), anti-E (E antigen), anti-Duffy (Fya), anti-Kidd (Jka/Jkb), anti-MNS. A positive ICT with non-anti-D specificity still requires fetal monitoring with MCA Doppler. Anti-Kell in particular is treated as seriously as anti-Rh D — or more so — because it not only haemolyses fetal cells but suppresses new red cell production (erythroid suppression), causing more severe fetal anaemia at lower titres.
What Happens After a Positive Coombs Test?
A positive DCT in a patient with anaemia triggers a full haemolytic anaemia workup: CBC with reticulocyte count (reticulocytosis = bone marrow compensating for haemolysis), peripheral blood smear (spherocytes = warm AIHA; agglutinated RBCs = cold AIHA), serum LDH (elevated — from RBC breakdown), serum bilirubin — indirect fraction elevated (from haemoglobin catabolism to unconjugated bilirubin), plasma haptoglobin (low or undetectable — haptoglobin binds free haemoglobin and is consumed in haemolysis), urinalysis (haemoglobinuria = dark brown urine = intravascular haemolysis). Antibody specificity testing on the positive DCT — is it IgG, IgM, C3d, or mixed? This determines whether it is warm or cold AIHA and guides treatment.
First-line: Prednisolone 1 mg/kg/day — induces remission in 70–80% of patients within 3 weeks. Taper slowly over 3–6 months monitoring Hb, reticulocytes, and DCT. Second-line (steroid-refractory or dependent): Rituximab (anti-CD20 monoclonal antibody) — increasingly available in India, achieves remission in 70–80% of refractory cases; Azathioprine, MMF (mycophenolate) as steroid-sparing agents; Splenectomy (for chronic refractory cases). Blood transfusion: required for severe symptomatic anaemia (Hb below 6 g/dL with symptoms) — challenging because antibody is often panreactive (reacts with all donor cells); use least-incompatible blood with haematologist guidance. Underlying disease treatment: treat lymphoma, SLE, infections causing secondary AIHA.
Titre below 1:16: monthly titre monitoring, identify antibody specificity, standard antenatal care. Titre 1:16 and above: MCA (Middle Cerebral Artery) Doppler ultrasound every 1–2 weeks — MCA peak systolic velocity (PSV) above 1.5 MoM indicates moderate-severe fetal anaemia requiring intervention. Severe fetal anaemia on Doppler: Intrauterine transfusion (IUT) — transfusion of O negative, CMV-negative, irradiated, packed red cells directly into the fetal umbilical vein under ultrasound guidance. Birth planning: delivery at a centre with neonatal ICU; cord blood DCT at birth; phototherapy and exchange transfusion for the neonate as needed.
Jaundice in the first 24 hours of life is always pathological. Positive cord blood or neonatal DCT confirms an immune cause. The most common cause in Indian neonatal wards: ABO incompatibility (O mother, A or B baby) — usually mild, managed with phototherapy. Management escalation based on bilirubin rate of rise: Phototherapy (first-line) → Double phototherapy → Exchange transfusion (when bilirubin approaching kernicterus threshold — especially important in premature infants). Monitor haemoglobin — late anaemia (week 3–8 of life) from ongoing low-grade HDFN can occur after the jaundice phase resolves, requiring vigilance during neonatal follow-up.
✅ Book Indirect Coombs Test (ICT) — Antenatal Antibody Screening
The ICT is an essential part of antenatal care for all pregnant women in India — particularly for Rh-negative women and for pre-transfusion compatibility testing:
Affiliate link: I may earn a small commission at no extra cost to you. The Direct Coombs Test (DCT) for AIHA investigation is ordered by your haematologist and is available at all major diagnostic labs. Always have Coombs test results interpreted by your obstetrician (for ICT in pregnancy) or haematologist (for DCT in anaemia workup).
ICT (इनडायरेक्ट कूम्ब्स टेस्ट) हर Rh नेगेटिव गर्भवती महिला के लिए प्रसव पूर्व देखभाल का अनिवार्य हिस्सा है। परिणाम हमेशा अपने प्रसूति विशेषज्ञ से समझें। Supportive Care During Haemolytic Anaemia Treatment
Autoimmune haemolytic anaemia treatment (steroids, immunosuppressants) and monitoring requires regular temperature tracking and addressing nutritional deficiencies that commonly co-exist. Always consult your haematologist before starting any supplement — particularly during active steroid therapy.
Patients with AIHA often have an underlying infection trigger (Mycoplasma, viral illness) or are on immunosuppressive therapy (steroids, rituximab) which increases infection risk. Regular temperature monitoring is essential during treatment — fever during immunosuppression may indicate a serious infection requiring urgent attention. The Dr Trust flexible-tip thermometer is widely used by Indian patients for accurate, fast, at-home temperature tracking. Contact your doctor immediately if fever develops while on immunosuppressive therapy.
View on Amazon IndiaAffiliate link — small commission at no extra cost to you.
Vitamin B12 deficiency anaemia (megaloblastic anaemia) is a very common differential diagnosis for haemolytic anaemia in India — both can cause elevated bilirubin and elevated LDH, and misdiagnosis is common without a Coombs test. Many patients with confirmed AIHA also have co-existing B12 deficiency (particularly vegetarians — extremely prevalent in India). B12 deficiency impairs red cell production and can worsen anaemia during AIHA. Active methylcobalamin (the bioavailable form of B12) supports nerve function and red cell production. Always consult your haematologist before starting any supplement — B12 supplementation is only indicated if deficiency is confirmed on blood testing.
View on Amazon IndiaAffiliate link — small commission at no extra cost to you.
Related Tests / संबंधित जांचें
These tests are commonly ordered alongside the Coombs test in India:
कूम्ब्स टेस्ट के साथ ये जांचें अक्सर करवाई जाती हैं:Frequently Asked Questions / अक्सर पूछे जाने वाले सवाल
The Direct Coombs Test (DCT) tests the patient's own red blood cells — it detects antibodies already coating the patient's RBCs (in vivo sensitisation). It answers: "Are my red blood cells being attacked right now?" A positive DCT is used to diagnose autoimmune haemolytic anaemia, haemolytic transfusion reactions, and haemolytic disease of the newborn. The Indirect Coombs Test (ICT) tests the patient's blood serum — it detects free antibodies circulating in the serum that are capable of reacting with red blood cells in a test tube (in vitro). It answers: "Does my blood contain antibodies that could attack red blood cells?" The ICT is used for: antenatal screening of Rh-negative pregnant women (to check for anti-Rh D sensitisation), pre-transfusion cross-matching (compatibility testing), and investigation of unexpected blood group antibodies. Think of DCT as a test of what is happening inside you now, and ICT as a test of what your blood could do if it encountered certain red blood cells.
उत्तर: DCT = रोगी की स्वयं की RBC पर एंटीबॉडी का पता लगाता है (अभी क्या हो रहा है?)। ICT = रोगी के सीरम में मुक्त एंटीबॉडी का पता लगाता है (क्या मेरे रक्त में RBC को नुकसान पहुंचाने वाले एंटीबॉडी हैं?)।A positive DCT does not mean blood cancer and should not cause panic. There are many causes of a positive DCT — most of them treatable or benign. The most common cause is drug-induced (many antibiotics, particularly penicillin and cephalosporins commonly given in Indian hospitals, cause a positive DCT — stopping the drug resolves the test). Other common causes include autoimmune haemolytic anaemia (AIHA — most cases respond well to steroids), infections (Mycoplasma pneumoniae causing cold-agglutinin type), recent blood transfusion, and secondary AIHA from SLE. Lymphoma and CLL (blood cancers) do cause AIHA, but they are responsible for a minority of AIHA cases — and even then, AIHA is a treatable complication of those diseases. Your haematologist will evaluate the positive DCT alongside your full clinical picture (symptoms, CBC, bilirubin, LDH, peripheral smear, medication history) to determine the cause. In many hospitalised patients, a positive DCT is found incidentally without any clinical haemolysis — in which case it may not require specific treatment.
उत्तर: पॉजिटिव DCT का मतलब ब्लड कैंसर नहीं है। सबसे आम कारण: दवा-प्रेरित (एंटीबायोटिक्स), ऑटोइम्यून हेमोलिटिक एनीमिया (स्टेरॉयड से उपचार योग्य), संक्रमण। हेमेटोलॉजिस्ट पूरी नैदानिक तस्वीर के साथ कारण निर्धारित करेंगे।Not necessarily — each pregnancy and sensitising event carries a risk of converting the ICT from negative to positive. In the first pregnancy, the ICT is almost always negative (unless you received Rh-positive blood in a prior transfusion). But each delivery of an Rh-positive baby, miscarriage, abortion, amniocentesis, or abdominal trauma carries a risk of fetal blood entering the maternal circulation — and if Anti-D immunoglobulin is not given within 72 hours of each of these events, sensitisation can occur. A second or third Rh-positive pregnancy without proper Anti-D coverage significantly increases the risk of ICT becoming positive. Once the ICT becomes positive, it cannot be reversed — the anti-Rh D antibodies are permanent. This is why Anti-D must be given at every sensitising event throughout your reproductive life — not just for first pregnancies. Even if your ICT was negative in pregnancy 1 and you received Anti-D, you must repeat ICT in pregnancy 2 (and all subsequent pregnancies) and ensure Anti-D is given again at 28 weeks and after delivery each time.
उत्तर: जरूरी नहीं — हर गर्भावस्था और संवेदनशीलता घटना (प्रसव, गर्भपात, एम्नियोसेंटेसिस) ICT को पॉजिटिव करने का जोखिम रखती है। Anti-D हर गर्भावस्था में और हर संवेदनशीलता घटना के 72 घंटे के भीतर देना अनिवार्य है।A rising ICT titre during pregnancy is a serious finding that requires immediate escalation of monitoring. The titre (1:4, 1:8, 1:16, 1:32, etc.) measures the concentration of anti-Rh D (or other blood group) antibodies in your serum — higher numbers mean more antibodies. The critical titre threshold in Indian obstetric practice is 1:16 — at or above this level, the risk of significant fetal anaemia becomes real. A rising titre from 1:4 to 1:16 means the maternal immune response is strengthening, and more antibodies are crossing the placenta to attack the baby's red cells. What happens now: you will need MCA (Middle Cerebral Artery) Doppler ultrasound every 1–2 weeks to measure fetal blood flow — elevated MCA peak systolic velocity (above 1.5 MoM) indicates fetal anaemia requiring intervention. You will likely be referred to a maternal-fetal medicine specialist. If fetal anaemia is confirmed, intrauterine transfusion (IUT) may be needed. Do not delay — contact your obstetrician immediately when you receive this result.
उत्तर: बढ़ता ICT टाइटर (1:4 → 1:16) = गंभीर निष्कर्ष। 1:16 और ऊपर = MCA Doppler अल्ट्रासाउंड हर 1–2 सप्ताह। MCA PSV >1.5 MoM = भ्रूण एनीमिया = इंट्रायूटेराइन ट्रांसफ्यूजन की जरूरत हो सकती है। तुरंत प्रसूति विशेषज्ञ से संपर्क करें।No — fasting is not required for either the Direct Coombs Test (DCT) or the Indirect Coombs Test (ICT). Both tests detect antibodies — either on red blood cells (DCT) or in serum (ICT) — and antibody levels are not affected by food intake, time of day, or fasting status. You can eat and drink normally before providing the blood sample. No special preparation is needed before the Coombs test — no medications need to be stopped (though your doctor will review your medication list as part of the investigation). The only practical consideration: if the Coombs test is being sent alongside other tests that require fasting (e.g., fasting blood sugar, lipid profile), follow the fasting instructions for those tests and the blood draw will cover all tests together from the same sample.
उत्तर: नहीं — DCT या ICT के लिए उपवास आवश्यक नहीं। एंटीबॉडी स्तर भोजन सेवन से प्रभावित नहीं होते। सामान्य खाना-पीना करके नमूना दे सकते हैं।A positive DCT in a newborn with jaundice confirms an immune (haemolytic) cause of the jaundice — this is important information but does not automatically mean danger. The most common cause in Indian neonatal wards is ABO incompatibility (mother is blood group O, baby is A or B) — this is usually mild and managed effectively with phototherapy alone. Rh incompatibility (Rh-negative mother, Rh-positive baby) can be more severe, particularly in second or subsequent sensitised pregnancies without Anti-D coverage. The key risk is kernicterus (bilirubin depositing in the brain — causing permanent brain damage) if jaundice is not treated promptly. The danger depends on: how fast bilirubin is rising, the gestational age of the baby (premature babies are at higher risk at lower bilirubin levels), and the clinical condition of the baby. The neonatal team will monitor bilirubin levels every 4–6 hours and escalate from phototherapy to double phototherapy to exchange transfusion if levels approach dangerous thresholds. With prompt treatment, the vast majority of neonates with positive DCT and haemolytic jaundice recover completely without complications.
उत्तर: नवजात में पॉजिटिव DCT = जन्डिस का प्रतिरक्षा कारण पुष्ट। सबसे आम: ABO असंगतता (हल्की, फोटोथेरेपी से उपचार)। Rh असंगतता अधिक गंभीर हो सकती है। समय पर उपचार (फोटोथेरेपी → डबल फोटोथेरेपी → एक्सचेंज ट्रांसफ्यूजन) से अधिकांश नवजात पूरी तरह ठीक होते हैं।- MedlinePlus (NIH): Coombs Tests — Patient Information
- British Society for Haematology: BSH Guidelines — Haemolytic Disease of the Fetus and Newborn
- American Society of Hematology (ASH): Haemolytic Anaemia Patient Information
⚠️ Medical Disclaimer / चिकित्सा अस्वीकरण
This article is for educational purposes only. Coombs test results must always be interpreted by a qualified haematologist (for DCT in anaemia workup) or obstetrician (for ICT in pregnancy) alongside the full clinical picture, CBC, bilirubin, LDH, peripheral smear, and medication history. Never self-diagnose or change medications based on this guide. A positive ICT in pregnancy requires immediate specialist referral — do not delay.
यह लेख केवल शैक्षिक उद्देश्यों के लिए है। कूम्ब्स टेस्ट परिणाम हमेशा योग्य हेमेटोलॉजिस्ट (DCT) या प्रसूति विशेषज्ञ (ICT) द्वारा पूर्ण नैदानिक संदर्भ में व्याख्या किए जाने चाहिए। गर्भावस्था में पॉजिटिव ICT के लिए तुरंत विशेषज्ञ के पास जाएं।
Comments
Post a Comment